Trading · Founded 2006 · www.yashchemex.com · BSE 539939 · · ISIN INE571U01010
No Notes Added Yet
Business
Yash Chemex Ltd. is an Indian company primarily engaged in the manufacturing and trading of chemical products. Its core business involves the production of reactive dyes, and the broader trading of various dyestuffs, intermediates, pigments, and other specialty chemicals. The company serves industrial clients in both domestic and international markets, acting as a manufacturer, supplier, and distributor. Revenue is generated from the sale of its manufactured products and through margins on its diverse traded chemical portfolio.
Revenue Mix
The company operates in two primary segments:
Manufacturing: Focuses on the production of reactive dyes.
Trading: Involves the sourcing and distribution of a wide range of chemicals, dyestuffs, intermediates, and pigments.
Precise revenue contribution percentages for each segment are not readily available without deep analysis of recent financial statements.
Industry
Yash Chemex operates within the highly diverse and competitive Indian chemical industry, specifically in the dyes & intermediates sector and the broader chemical trading space. The chemical trading industry is characterized by numerous players, reliance on efficient supply chains, and price competitiveness. In manufacturing reactive dyes, it competes with other domestic and international producers. Given its size, Yash Chemex likely operates as a niche or regional player, focusing on specific product categories and customer segments rather than being a large-scale, diversified chemical conglomerate.
MOAT
Yash Chemex operates in industries where durable moats are generally challenging to establish for smaller players. Its potential competitive advantages are likely derived from:
Established Supplier and Customer Relationships: Long-standing trust and networks for sourcing and distribution.
Product Specialization/Niche Focus: Expertise in specific dyestuffs or chemical intermediates that cater to particular industrial needs.
Cost Efficiency in Manufacturing: Potentially efficient processes for reactive dye production.
However, broad scale advantages, strong brand recognition (beyond specific B2B circles), or high switching costs are less apparent, making its competitive position vulnerable to price competition and market fluctuations.
Growth Drivers
Growth in End-User Industries: Increasing demand from sectors like textiles, paints, plastics, and other manufacturing industries that consume dyes and chemicals.
Product Portfolio Expansion: Introduction of new chemical products or dye types to cater to evolving market needs and expand customer base.
Geographic Expansion: Increasing penetration in new domestic regions or expanding export markets for its manufactured and traded products.
Increased Manufacturing Capacity: Scaling up production of reactive dyes to meet growing demand.
Risks
Commodity Price Volatility: Fluctuations in raw material prices (for manufacturing) and traded chemical prices can significantly impact profit margins.
Foreign Exchange Risk: As an entity involved in international trade, adverse currency movements can affect profitability.
Intense Competition: The chemical manufacturing and trading sectors in India are highly competitive, leading to potential pricing pressures and market share erosion.
Regulatory Changes: Evolving environmental norms, import/export policies, and chemical safety regulations can increase operational costs and compliance burdens.
Supply Chain Disruptions: Geopolitical events, logistical challenges, or natural disasters can disrupt the sourcing and distribution of chemicals.
Credit Risk: For trading activities, extending credit to customers involves the risk of defaults or delayed payments.
Management & Ownership
Yash Chemex Ltd. is a promoter-driven company, with Mr. Yash Pal Gupta and his family being the key promoters. As is common with many small-cap Indian companies, promoter shareholding typically constitutes a significant portion of the total equity, indicating strong owner-operator alignment. Information on the broader management team's specific track record and expertise would require deeper scrutiny of company reports and public disclosures.
Outlook
Yash Chemex operates in the dynamic Indian chemical industry, which presents both opportunities and challenges. Its blended business model of manufacturing reactive dyes and trading a diverse range of chemicals offers some diversification. The company's future performance will largely depend on its ability to effectively manage raw material price volatility, navigate intense competitive pressures, expand its product offerings, and efficiently serve its customer base. While the growing chemical sector provides tailwinds, the inherent low-margin nature of trading and the fragmented competitive landscape for specialty chemicals mean that consistent, high-margin growth may require strategic differentiation and operational excellence.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 25 | 14 | 24 | 27 | 30 | 30 | 39 | 34 | 41 | 17 |
| Other Income | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 2 | 1 | 1 |
| Total Income | 26 | 14 | 25 | 28 | 31 | 30 | 39 | 36 | 42 | 19 |
| Total Expenditure | 29 | 11 | 23 | 27 | 30 | 29 | 37 | 34 | 42 | 17 |
| Operating Profit | -4 | 2 | 2 | 0 | 1 | 1 | 2 | 2 | -0 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -4 | 2 | 1 | -0 | 1 | 1 | 1 | 1 | -0 | 1 |
| Provision for Tax | -1 | 1 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -3 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | -0 | 1 |
| Adjustments | 1 | -0 | -0 | 0 | -0 | -0 | -0 | -0 | 0 | -0 |
| Profit After Adjustments | -2 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | -0 | 1 |
| Adjusted Earnings Per Share | -2.4 | 0.9 | 0.6 | 0.3 | 0.2 | 0.6 | 0.7 | 0.8 | -0.1 | 0.8 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 78 | 85 | 99 | 78 | 56 | 98 | 85 | 95 | 95 | 131 |
| Other Income | 1 | 2 | 0 | 2 | 1 | 2 | 6 | 2 | 2 | 4 |
| Total Income | 79 | 87 | 99 | 80 | 58 | 100 | 91 | 97 | 98 | 136 |
| Total Expenditure | 77 | 84 | 95 | 76 | 53 | 94 | 85 | 95 | 92 | 130 |
| Operating Profit | 1 | 3 | 4 | 4 | 4 | 6 | 6 | 2 | 6 | 6 |
| Interest | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 3 | 4 | 4 | 4 | 5 | 5 | -0 | 4 | 3 |
| Provision for Tax | 0 | 1 | 1 | 1 | 1 | 1 | 1 | -0 | 1 | 0 |
| Profit After Tax | 1 | 2 | 3 | 3 | 3 | 3 | 4 | 0 | 3 | 3 |
| Adjustments | 0 | -0 | -0 | -1 | -1 | -1 | -1 | -1 | -1 | 0 |
| Profit After Adjustments | 1 | 2 | 2 | 2 | 2 | 3 | 3 | -0 | 2 | 3 |
| Adjusted Earnings Per Share | 0.6 | 1.8 | 2.2 | 2.3 | 1.9 | 2.5 | 2.7 | -0.3 | 2 | 2.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 0% | -1% | 4% | 0% |
| Operating Profit CAGR | 200% | 0% | 8% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -51% | -6% | 4% | 18% |
| ROE Average | 8% | 8% | 10% | 11% |
| ROCE Average | 11% | 10% | 13% | 15% |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 13 | 14 | 17 | 21 | 23 | 26 | 29 | 36 | 38 |
| Minority's Interest | 0 | 4 | 8 | 8 | 9 | 9 | 7 | 19 | 20 |
| Borrowings | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 |
| Other Non-Current Liabilities | -0 | -0 | 0 | 1 | 1 | 1 | 3 | 2 | 2 |
| Total Current Liabilities | 29 | 24 | 25 | 24 | 26 | 32 | 27 | 20 | 25 |
| Total Liabilities | 42 | 41 | 51 | 55 | 59 | 68 | 68 | 77 | 85 |
| Fixed Assets | 0 | 0 | 1 | 1 | 1 | 1 | 5 | 5 | 5 |
| Other Non-Current Assets | 0 | 3 | 6 | 8 | 13 | 13 | 13 | 11 | 11 |
| Total Current Assets | 42 | 38 | 44 | 46 | 45 | 54 | 50 | 62 | 69 |
| Total Assets | 42 | 41 | 51 | 55 | 59 | 68 | 68 | 77 | 85 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow from Operating Activities | -2 | 1 | -0 | 0 | 1 | -3 | 5 | -18 | -1 |
| Cash Flow from Investing Activities | 0 | -3 | -2 | 0 | -4 | -0 | -6 | 3 | 0 |
| Cash Flow from Financing Activities | 2 | 2 | 3 | -1 | 4 | 4 | 1 | 15 | 0 |
| Net Cash Inflow / Outflow | 0 | 0 | 0 | -0 | -0 | -0 | 0 | 0 | 0 |
| Closing Cash & Cash Equivalent | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.61 | 1.79 | 2.24 | 2.33 | 1.86 | 2.47 | 2.73 | -0.27 | 2.01 |
| CEPS(Rs) | 0.64 | 1.94 | 2.68 | 3.02 | 2.62 | 3.47 | 3.84 | 0.43 | 2.87 |
| DPS(Rs) | 0 | 0.35 | 0.3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 12.92 | 13.54 | 16.76 | 20.21 | 22.09 | 25.08 | 28.55 | 34.7 | 36.75 |
| Core EBITDA Margin(%) | 0.78 | 1.79 | 3.56 | 3.57 | 5.33 | 3.71 | -0.08 | -0.03 | 3.22 |
| EBIT Margin(%) | 1.58 | 3.58 | 3.84 | 5.37 | 7.51 | 5.58 | 6.92 | 1.56 | 5.71 |
| Pre Tax Margin(%) | 1.07 | 3.26 | 3.73 | 5.12 | 6.39 | 4.69 | 5.53 | -0.07 | 4.07 |
| PAT Margin (%) | 0.73 | 2.26 | 2.63 | 3.76 | 4.45 | 3.49 | 4.47 | 0.35 | 2.98 |
| Cash Profit Margin (%) | 0.77 | 2.29 | 2.77 | 3.94 | 4.74 | 3.63 | 4.6 | 0.47 | 3.08 |
| ROA(%) | 1.47 | 4.7 | 5.67 | 5.6 | 4.4 | 5.35 | 5.62 | 0.45 | 3.49 |
| ROE(%) | 4.71 | 14.43 | 16.75 | 15.59 | 11.61 | 14.12 | 13.89 | 1.01 | 7.75 |
| ROCE(%) | 8.35 | 19.43 | 21.95 | 20.22 | 16.45 | 16.95 | 15.64 | 3.46 | 11.43 |
| Receivable days | 163.73 | 148.8 | 121.89 | 150.23 | 215.32 | 141.23 | 158.09 | 144.23 | 159.09 |
| Inventory Days | 12.53 | 15.26 | 20.41 | 27.28 | 35.56 | 28.76 | 49.41 | 59.65 | 73.71 |
| Payable days | 123.67 | 103.46 | 87.26 | 111.67 | 141.17 | 78.47 | 81.92 | 53.58 | 41.86 |
| PER(x) | 27.05 | 29.69 | 38.87 | 30.21 | 22.36 | 23.89 | 25.56 | 0 | 24.26 |
| Price/Book(x) | 1.27 | 3.92 | 5.19 | 3.48 | 1.88 | 2.35 | 2.44 | 1.61 | 1.32 |
| Dividend Yield(%) | 0 | 0.66 | 0.34 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.25 | 0.66 | 0.91 | 0.94 | 0.84 | 0.71 | 0.95 | 0.7 | 0.62 |
| EV/Core EBITDA(x) | 14.16 | 17.84 | 22.9 | 16.97 | 10.77 | 12.38 | 13.4 | 41.48 | 10.74 |
| Net Sales Growth(%) | 0 | 8.91 | 16.32 | -20.7 | -28.03 | 73.21 | -12.78 | 11.22 | 0.39 |
| EBIT Growth(%) | 0 | 130.01 | 22.17 | 10.94 | 0.73 | 28.64 | 8.23 | -74.98 | 268.02 |
| PAT Growth(%) | 0 | 214.19 | 32.93 | 13.55 | -14.85 | 35.72 | 11.82 | -91.39 | 763.09 |
| EPS Growth(%) | 0 | 193.98 | 25.34 | 3.84 | -20.09 | 32.76 | 10.51 | -109.8 | 850.69 |
| Debt/Equity(x) | 0.22 | 0.14 | 0.09 | 0.11 | 0.27 | 0.39 | 0.36 | 0.28 | 0.32 |
| Current Ratio(x) | 1.44 | 1.6 | 1.72 | 1.89 | 1.75 | 1.7 | 1.85 | 3.09 | 2.72 |
| Quick Ratio(x) | 1.34 | 1.42 | 1.46 | 1.69 | 1.52 | 1.4 | 1.34 | 2.22 | 1.88 |
| Interest Cover(x) | 3.09 | 11.09 | 36.02 | 22.03 | 6.68 | 6.29 | 4.99 | 0.95 | 3.49 |
| Total Debt/Mcap(x) | 0.18 | 0.04 | 0.02 | 0.03 | 0.14 | 0.17 | 0.15 | 0.17 | 0.24 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 63.53 | 63.53 | 63.58 | 63.93 | 64.31 | 64.38 | 64.46 | 64.61 | 64.61 | 64.61 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 36.47 | 36.47 | 36.42 | 36.07 | 35.69 | 35.62 | 35.54 | 35.39 | 35.39 | 35.39 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.65 | 0.65 | 0.65 | 0.65 | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.37 | 0.37 | 0.37 | 0.37 | 0.37 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 0% | -1% | +4% | — |
| Operating Profit CAGR | +200% | 0% | +8% | — |
| PAT CAGR | — | 0% | 0% | — |
| Share Price CAGR | -51% | -6% | +4% | +18% |
| ROE Average | +8% | +8% | +10% | +11% |
| ROCE Average | +11% | +10% | +13% | +15% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 63.53 | 63.53 | 63.58 | 63.93 | 64.31 | 64.38 | 64.46 | 64.61 | 64.61 | 64.61 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 36.47 | 36.47 | 36.42 | 36.07 | 35.69 | 35.62 | 35.54 | 35.39 | 35.39 | 35.39 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.65 | 0.65 | 0.65 | 0.65 | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.37 | 0.37 | 0.37 | 0.37 | 0.37 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.